BIO-key International Inc. (NASDAQ:BKYI) went up by 60.01% from its latest closing price compared to the recent 1-year high of $2.58. The company’s stock price has collected -4.46% of loss in the last five trading sessions. Press Release reported 13 min ago that U.S. General Services Administration (GSA) Deploys BIO-key’s PortalGuard Identity and Access Management (IAM) Solution for Two-factor Authentication Compliance
Is It Worth Investing in BIO-key International Inc. (NASDAQ :BKYI) Right Now?
Plus, the 36-month beta value for BKYI is at 1.08. Opinions of the stock are interesting as 0 analysts out of 1 who provided ratings for BIO-key International Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $2.00. BKYI currently public float of 52.55M and currently shorts hold a 0.66% ratio of that float. Today, the average trading volume of BKYI was 7.73M shares.
BKYI’s Market Performance
BKYI stocks went down by -4.46% for the week, with a monthly drop of -18.74% and a quarterly performance of -46.82%, while its annual performance rate touched -29.98%. The volatility ratio for the week stands at 5.99% while the volatility levels for the past 30 days are set at 6.85% for BIO-key International Inc.. The simple moving average for the period of the last 20 days is 46.95% for BKYI stocks with a simple moving average of -4.29% for the last 200 days.
BKYI Trading at 15.55% from the 50-Day Moving Average
After a stumble in the market that brought BKYI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -73.95% of loss for the given period.
Volatility was left at 6.85%, however, over the last 30 days, the volatility rate increased by 5.99%, as shares surge +35.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.86% lower at present.
During the last 5 trading sessions, BKYI rose by +49.77%, which changed the moving average for the period of 200-days by +25.52% in comparison to the 20-day moving average, which settled at $0.4660. In addition, BIO-key International Inc. saw -15.98% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at BKYI starting from DEPASQUALE MICHAEL W, who purchase 5,000 shares at the price of $0.83 back on Jun 11. After this action, DEPASQUALE MICHAEL W now owns 20,417 shares of BIO-key International Inc., valued at $4,150 using the latest closing price.
DEPASQUALE MICHAEL W, the Pres., CEO & Director of BIO-key International Inc., purchase 5,000 shares at $0.95 during a trade that took place back on Jun 10, which means that DEPASQUALE MICHAEL W is holding 15,417 shares at $4,750 based on the most recent closing price.
Stock Fundamentals for BKYI
Current profitability levels for the company are sitting at:
- -289.40 for the present operating margin
- -14.66 for the gross margin
The net margin for BIO-key International Inc. stands at -643.37. The total capital return value is set at -119.34, while invested capital returns managed to touch -340.40.
When we switch over and look at the enterrpise to sales, we see a ratio of 4.12, with the company’s debt to enterprise value settled at 0.30. The receivables turnover for the company is 2.43 and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.31.